Structures by: Yamuna T. S.
Total: 22
Pyrimethaminium 2-{[4-(trifluoromethyl)phenyl]sulfanyl}benzoate dimethyl sulfoxide monosolvate
C12H14ClN4,C14H8F3O2S,C2H6OS
Acta Crystallographica Section E (2014) 70, 6 o683-o684
a=12.7422(3)Å b=22.2773(3)Å c=11.1761(3)Å
α=90° β=114.014(3)° γ=90°
4-pyrimidin-2-yl-piperazin-1-ium fumarate
C8H13N4,C4H3O4
Acta Crystallographica Section E (2014) 70, 6 o702-o703
a=12.3425(5)Å b=7.0365(3)Å c=14.7178(6)Å
α=90° β=94.213(3)° γ=90°
3-Amino-1<i>H</i>-pyrazol-2-ium trifluoroacetate
C3H6N3,C2F3O2
Acta Crystallographica Section E (2013) 69, 9 o1425-o1426
a=10.9292(8)Å b=10.9332(6)Å c=13.7002(13)Å
α=90° β=107.939(9)° γ=90°
4-Hydroxy-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-6(5<i>H</i>)-one dihydrate
C15H12N4O4,2(H2O)
Acta Crystallographica Section E (2013) 69, 11 o1707-o1708
a=9.5817(3)Å b=13.9439(3)Å c=12.4804(4)Å
α=90° β=109.832(3)° γ=90°
2-[4-(Trifluoromethyl)phenylsulfanyl]benzoic acid
C14H9F3O2S
Acta Crystallographica Section E (2013) 69, 11 o1704
a=7.3071(5)Å b=8.0790(7)Å c=11.3878(11)Å
α=82.678(8)° β=83.642(7)° γ=72.309(7)°
Raltegravir monohydrate
C20H21FN6O5,H2O
Acta Crystallographica Section E (2013) 69, 12 o1743-o1744
a=8.3860(6)Å b=11.8610(9)Å c=12.1102(9)Å
α=110.481(7)° β=108.093(7)° γ=92.329(6)°
3-(4-Fluorophenyl)-1<i>H</i>-pyrazole--5-(4-fluorophenyl)-1<i>H</i>-pyrazole (1/1)
C9H7FN2
Acta Crystallographica Section E (2014) 70, 9 o949-o950
a=10.3961(5)Å b=10.8565(6)Å c=16.1431(7)Å
α=84.704(4)° β=76.223(4)° γ=68.249(5)°
<i>N</i>-(3-Benzoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)benzamide
C22H19NO2S
Acta Crystallographica Section E (2014) 70, 9 o951-o952
a=13.5223(4)Å b=6.23222(15)Å c=22.2941(6)Å
α=90° β=106.150(3)° γ=90°
Flupentixol tartrate
C23H26F3N2OS,C4H5O6
Acta Crystallographica Section E (2014) 70, 2 o206-o207
a=9.9239(3)Å b=9.1968(3)Å c=30.0099(8)Å
α=90° β=96.617(3)° γ=90°
5-Aminopyrazol-2-ium hydrogen succinate
C3H6N3,C4H5O4
Acta Crystallographica Section E (2014) 70, 2 o221-o222
a=18.525(3)Å b=6.7872(9)Å c=14.564(3)Å
α=90° β=108.900(18)° γ=90°
Enrofloxacinium oxalate
2(C19H23FN3O3),C2O42
Acta Crystallographica Section E (2014) 70, 2 o200-o201
a=9.8552(5)Å b=13.3056(8)Å c=15.6124(8)Å
α=68.987(5)° β=84.740(4)° γ=73.093(5)°
3-(1<i>H</i>-Imidazol-1-yl)propanaminium picrate
C6H2N3O7,C6H12N3
Acta Crystallographica Section E (2013) 69, 10 o1572-o1573
a=11.98275(18)Å b=38.5234(6)Å c=16.4239(2)Å
α=90° β=94.1970(14)° γ=90°
6-Chloro-2-chloromethyl-4-phenylquinazoline 3-oxide
C15H10Cl2N2O
Acta Crystallographica Section E (2014) 70, 4 o440-o441
a=8.2030(3)Å b=14.3203(5)Å c=11.8477(4)Å
α=90° β=105.016(4)° γ=90°
{2-[(1<i>H</i>-Indol-3-ylmethylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl}(phenyl)methanone
C24H20N2OS
Acta Crystallographica Section E (2014) 70, 4 o501-o502
a=8.66858(16)Å b=21.8200(4)Å c=10.41956(18)Å
α=90° β=108.1709(19)° γ=90°
5-(4-fluoro-phenyl)-2H-pyrazol-1-ium trifluoro-acetate
C9H8FN2,C2F3O2
Acta Crystallographica Section E (2014) 70, 4 o429-o430
a=6.7828(2)Å b=16.8263(6)Å c=10.4004(4)Å
α=90° β=93.354(3)° γ=90°
{2-[(2-Bromo-5-methoxybenzylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl}(phenyl)methanone
C23H20BrNO2S
Acta Crystallographica Section E (2014) 70, 5 o581-o582
a=8.84813(17)Å b=12.5563(2)Å c=18.4384(4)Å
α=90° β=102.363(2)° γ=90°
1-3-aminopropyl imidazolium 3,5- dinitrosalicylate
C6H12N3,C7H3N2O7
Acta Crystallographica Section E (2014) 70, 3 o318-o319
a=7.0109(4)Å b=10.6617(8)Å c=10.7454(7)Å
α=93.075(6)° β=95.863(5)° γ=104.944(6)°
(2<i>E</i>)-1-(4-Chlorophenyl)-3-(4-nitrophenyl)prop-2-en-1-one
C15H10ClNO3
Acta Crystallographica Section E (2013) 69, 5 o790-o791
a=42.9266(17)Å b=5.9741(3)Å c=5.0680(2)Å
α=90° β=90° γ=90°
Methyl 2-[4-(trifluoromethyl)phenylsulfanyl]benzoate
C15H11F3O2S
Acta Crystallographica Section E (2013) 69, 11 o1670
a=11.0675(5)Å b=8.0429(3)Å c=15.6614(7)Å
α=90° β=96.654(5)° γ=90°
3-[4-(Pyrimidin-2-yl)piperazin-1-ium-1-yl]butanoate
C12H18N4O2
Acta Crystallographica Section E (2014) 70, 9 o1063-o1064
a=13.5157(6)Å b=7.8454(3)Å c=12.2147(5)Å
α=90° β=106.884(5)° γ=90°
4-(Pyrimidin-2-yl)piperazin-1-ium chloride
C8H13N4,Cl
Acta Crystallographica Section E (2014) 70, 10 203-206
a=6.84764(17)Å b=7.27667(18)Å c=19.1751(5)Å
α=90° β=90° γ=90°
4-(Pyrimidin-2-yl)piperazin-1-ium nitrate
C8H13N4,NO3
Acta Crystallographica Section E (2014) 70, 10 203-206
a=10.5272(6)Å b=7.2230(3)Å c=14.1575(7)Å
α=90° β=107.341(6)° γ=90°